MedPath

A study to compare two different drugs for acute blood pressure control during pregnancy

Not Applicable
Conditions
Health Condition 1: null- pregnant women with hypertensive emergencies (BP more than 160 and or 110 mm of Hg at more than 24 weeks pregnancy)
Registration Number
CTRI/2014/12/005285
Lead Sponsor
Government of Himachal Pradesh
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

1.Age between 18 to 45 years,

2.Period of gestation > 24 weeks of gestation

3.Maternal Heart rate; 60-90 beats per minute

4.Reassuring fetal heart rate.

Exclusion Criteria

1.known case of heart disease (pre-existing angina)

2.Non-pregnancy related hypertension (diagnosed cases of chronic or secondary hypertension)

3.Allergy to either of the drug

4.Need for any acute emergency for cesarean section (Abruptio placentae, severe fetal bradycardia etc)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Time required to achieve target systolic BP of 150 mm of Hg or lower and diastolic BP of 100 mm of Hg or lower (both targets had to be fulfilled).Timepoint: 2 hours after delivery
Secondary Outcome Measures
NameTimeMethod
ï??Total number of antihypertensive dosages required to achieve the target BP (systolic BP of 150 mm of Hg or lower and diastolic BP of 100 mm of Hg or lower, both to be fulfilled) <br/ ><br>ï??Maternal heart rate profile during the study period <br/ ><br>ï??Maternal hypotension (BP less than 90/60 mm Hg) <br/ ><br>ï??Side effects profile (Nausea, Vomiting, Headache, dizziness, urticaria, flushing, pruritis, nasal congestion, conjunctivitis, palpitations) <br/ ><br>ï??Perinatal outcome <br/ ><br>Timepoint: 2 hours after delivery
© Copyright 2025. All Rights Reserved by MedPath